Expression of TRAP1 Predicts Poor Survival of Malignant Glioma Patients

Journal of Molecular Neuroscience

Volumn 55, Issue 1, 2015, Pages 62-68

  Li, Shuai ^a   Lv, Qingjie ^a   Sun, Hanxue ^a   Xue, Yixue ^a   Wang, Ping ^a   Liu, Libo ^a   Li, Zhiqing ^a   Li, Zhen ^a   Tian, Xin ^a   Liu, Yun Hui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Malignant glioma; Survival analysis; TRAP1

Indexed keywords

PEPTIDES AND PROTEINS; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN 90; TRAP1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; BRAIN TUMOR; CASE CONTROL STUDY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL;

ADULT; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GLIOMA; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84920818660     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0413-5     Document Type: Article

References (24)

1. Altieri DC, Stein GS, Lian JB, Languino LR (2012) TRAP-1, the mitochondrial Hsp90. Biochim Biophys Acta 1823:767–773
2. Avgeropoulos NG, Batchelor TT (1999) New treatment strategies for malignant gliomas. Oncologist 4:209–224
3. Canadian Cancer Society’s Steering Committee: Canadian Cancer Statistics (2010) Toronto: Canadian Cancer Society; 2012. http://www.cancer.ca/statistics
4. Costantino E, Maddalena F, Calise S, Piscazzi A, Tirino V, Fersini A, Ambrosi A, Neri V, Esposito F, Landriscina M (2009) TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer Lett 279:39–46
5. Ducray F, Idbaih A, Wang XW, Cheneau C, Labussiere M, Sanson M (2011) Predictive and prognostic factors for gliomas. Expert Rev Anticancer Ther 11:781–789
6. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275:3305–3312
7. Gupta K, Salunke P (2012) Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol 138:1971–1981
8. Hua G, Zhang Q, Fan Z (2007) Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem 282:20553–20560
9. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
10. Jin Y, Murata H, Sakaguchi M, Kataoka K, Watanabe M, Nasu Y, Kumon H, Huh NH (2012) Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1. Oncol Rep 27:695–699
11. Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ, Altieri DC (2007) Regulation of tumor cell mitochondrial homeostasis by an organelle-specific HSP90 chaperone network. Cell 131:257–270
12. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268
13. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225
14. Landriscina M, Amoroso MR, Piscazzi A, Esposito F (2010) Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol Oncol 117:177–182
15. Leav I, Plescia J, Goel HL, Li J, Jiang Z, Cohen RJ, Languino LR, Altieri DC (2010) Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am J Pathol 176:393–401
16. Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S, Kajimoto S, Shibayama-Imazu T, Nakaya K (2004) Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem 279:42503–42515
17. Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M, Esposito F (2007) Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 10:342–350
18. Neckers L, Kern A, Tsutsumi S (2007) Hsp90 inhibitors disrupt mitochondrial homeostasis in cancer cells. Chem Biol 14:1204–1206
19. Nguyen MC, Tu GH, Koprivnikar KE, Gonzalez-Edick M, Jooss KU, Harding TC (2010) Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy. Cancer Immunol Immunother 59:1313–1323
20. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5:e172
21. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62:10–29
22. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193
23. Xiang F, Huang YS, Shi XH, Zhang Q (2010) Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J 277:1929–1938
24. Zuehlke A, Johnson JL (2010) Hsp90 and co-chaperones twist the functions of diverse client proteins. Biopolymers 93:211–217